UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 157

Sortiert nach

Does the association between smoking and mortality differ due to frailty status? A secondary analysis from the Mexican Health and Aging Study

Age and ageing, 2022-12, Vol.51 (12)

2022

Volltextzugriff (PDF)

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

Gynecologic oncology, 2019-07, Vol.154 (1), p.110-117

2019

Volltextzugriff (PDF)

Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects

The Journal of infectious diseases, 2019-07, Vol.220 (3), p.411-419

2019

Volltextzugriff (PDF)

Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine

Vaccine, 2015-11, Vol.33 (48), p.6855-6864

2015

Volltextzugriff (PDF)

Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure

Respiratory medicine, 2022-11, Vol.204, p.107010-107010, Article 107010

2022

Volltextzugriff (PDF)

Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men

Contemporary clinical trials, 2022-04, Vol.115, p.106592-106592, Article 106592

2022

Volltextzugriff (PDF)

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

EClinicalMedicine, 2020-06, Vol.23, p.100401-100401, Article 100401

2020

Volltextzugriff (PDF)

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

The Lancet (British edition), 2009-06, Vol.373 (9679), p.1949-1957

2009

Volltextzugriff (PDF)

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia : A randomized controlled trial

Obstetrics and gynecology (New York. 1953), 2006, Vol.107 (1), p.18-27

2006

Volltextzugriff (PDF)

Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers

Respiratory research, 2018-12, Vol.19 (1), p.239-239, Article 239

2018

Volltextzugriff (PDF)

Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study

Therapeutic advances in respiratory disease, 2016-10, Vol.10 (5), p.383-390

2016

Volltextzugriff (PDF)

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

Human vaccines & immunotherapeutics, 2021-04, Vol.17 (4), p.943-949

2021

Volltextzugriff (PDF)

miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke

BMC pulmonary medicine, 2019-11, Vol.19 (1), p.227-227, Article 227

2019

Volltextzugriff (PDF)

Letter to the Editor in response to “N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to O.M. Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022”

Contemporary clinical trials, 2017-03, Vol.54, p.105-105

2017

Volltextzugriff (PDF)

Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials

Contemporary clinical trials, 2016-03, Vol.47, p.254-258

2016

Volltextzugriff (PDF)

Women with COPD from biomass smoke have reduced serum levels of biomarkers of angiogenesis and cancer, with EGFR predominating, compared to women with COPD from smoking

Chronic respiratory disease, 2021, Vol.18, p.14799731211005023

2021

Volltextzugriff (PDF)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (5), p.2078626-2078626

2022

Volltextzugriff (PDF)

Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations

ERJ open research, 2022-10, Vol.8 (4), p.183

2022

Volltextzugriff (PDF)

Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass

Biomolecules (Basel, Switzerland), 2019-12, Vol.9 (12), p.837

2019

Volltextzugriff (PDF)

Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo

The Journal of urology, 2006-04, Vol.175 (4), p.1422-1427

2006

Volltextzugriff (PDF)

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

Vaccine, 2008-01, Vol.26 (5), p.686-696

2008

Volltextzugriff (PDF)

Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs . screening strategies

Respiratory medicine, 2013-04, Vol.107 (4), p.580-586

2013

Volltextzugriff (PDF)

Mother-Infant Transfer of Anti-Human Papillomavirus (HPV) Antibodies following Vaccination with the Quadrivalent HPV (Type 6/11/16/18) Virus-Like Particle Vaccine

Clinical and Vaccine Immunology, 2012-06, Vol.19 (6), p.881-885

2012

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(146)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(81)
Humans
(58)
Female
(36)
Adult
(24)
Male
(24)
Human Papillomavirus
(20)
Middle Aged
(20)
Adolescent
(17)
Biological And Medical Sciences
(14)
Immunogenicity
(14)
Medical Sciences
(14)
Vaccines
(14)
Aged
(13)
General & Internal Medicine
(12)
Medicine, General & Internal
(12)
Medicine, Research & Experimental
(12)
Papillomavirus Infections - Prevention & Control
(12)
Research & Experimental Medicine
(12)
Double-Blind Method
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Does the association between smoking and mortality differ due to frailty status? A secondary analysis from the Mexican Health and Aging Study

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects

Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine

Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure

Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia : A randomized controlled trial

Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers

Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke

Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials

Women with COPD from biomass smoke have reduced serum levels of biomarkers of angiogenesis and cancer, with EGFR predominating, compared to women with COPD from smoking

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years

Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations

Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass

Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs . screening strategies

Mother-Infant Transfer of Anti-Human Papillomavirus (HPV) Antibodies following Vaccination with the Quadrivalent HPV (Type 6/11/16/18) Virus-Like Particle Vaccine

Suchergebnisse filtern